October 12, 2026

Trials of Bispecifics in Smoldering Myeloma Look Beyond Delaying Progression – Targeted Oncology

October 8, 2026

Case 3: Treatment for Relapsed Myeloma with 17p Deletion – Targeted Oncology

October 8, 2026

Cancer Today’s Fall 2026 Issue: Activity-based Groups for Survivors, Expanding Treatment Options in Multiple Myeloma, and More

October 7, 2026

Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies – Nature

October 6, 2026

Important New MMRF-Led Study Reveals Previously Unknown Immune Features in Multiple Myeloma Patients with African Ancestry

First and largest study of its kind used MMRF data to uncover distinct immune features in this patient population. The Black community bears a disproportionate burden of multiple myeloma in the U.S. Black individuals are twice as likely to be diagnosed with myeloma as other racial and ethnic groups and face the disease’s highest mortality […]